Medicare Compliance & Reimbursement

Overpayments:

EPOGEN, Rx CHARGES STAND OUT IN OUTPATIENT PAYMENT REVIEW

Providers of outpatient services should take note that their claims are under scrutiny by the HHS Office of Inspector General. In a recent audit report - part of a nationwide series of reviews - the OIG takes the measure of potentially excessive Medicare payments fiscal intermediary United Government Services made to institutional providers of outpatient services. What stood out in the review were claims for the drug Epogen - one dialysis facility incorrectly billed for 9.9 million units of the drug and was paid more than $80,000. Outpatient pharmacy charges also seemed excessive in some cases, the OIG says, with $1.3 million billed by one provider on only seven claims. In the past, such errors have been found out to be the result of clerical blunders, the watchdog agency notes in "Review of Potentially Excessive Medicare Payments United Government Services" (A-01-02-00516). The OIG adds that the apparent overpayments were isolated instances and didn't reflect widespread problems. Nevertheless, UGS is taking steps to address the issue. To see the report, go to http://oig.hhs.gov/oas/reports/region1/10200516.pdf.  
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All